Sponsor Pipeline

Vector Y Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07287397 Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS Amyotrophic Lateral Sclerosis Recruiting
Disease Areas
ALS (1)
Get alerts when Vector Y Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free